Orthocresol

Orthocresol

SCHEMBL4080689

CC(=O)O.Cc1ccccc1O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Orthocresol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 1/20 0.43
ESR2 known ✓ Q92731 1/20 0.43
TRPA1 O75762 2/20 0.48
ATM Q13315 1/20 0.48
ALDH1A1 P00352 6/20 0.46
HPGD P15428 6/20 0.46
KDM4E B2RXH2 5/20 0.46
CA12 O43570 3/20 0.46
CA2 P00918 3/20 0.46
CA14 Q9ULX7 3/20 0.46
CA4 P22748 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CA1 P00915 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
THRB P10828 1/20 0.46
HMGB1 P09429 1/20 0.46
CA6 P23280 1/20 0.46
NAPRT Q6XQN6 1/20 0.46
HSD17B10 Q99714 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orthocresol SCHEMBL6566573 0.92 TRPA1 (0.50) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL28747710 0.92 TRPA1 (0.50) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL18725587 0.92 TRPA1 (0.50) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL14856303 0.90 TRPA1 (0.48) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL3862455 0.89 TRPA1 (0.57) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL29233113 0.88 KDM4E (0.54) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL28822341 0.88 ALDH1A1 (0.54) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL27415541 0.88 TRPA1 (0.46) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL9648880 0.88 TRPA1 (0.46) TRPA1ATMALDH1A1HPGDKDM4E
Orthocresol SCHEMBL27628632 0.87 TRPA1 (0.55) TRPA1ATMALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US claimed
US-20240310341-A1 COLORIMETRIC SENSOR AND ITS PREPARATION PROCEDURE MATERIAS S.R.L. (IT) 2024-09-19 US disclosed
EP-4288765-A1 COLORIMETRIC SENSOR AND ITS PREPARATION PROCEDURE Materias S.r.l. (IT) 2023-12-13 EP disclosed
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
WO-2022167914-A1 COLORIMETRIC SENSOR AND ITS PREPARATION PROCEDURE MATERIAS S.R.L. (IT) 2022-08-11 WO disclosed
EP-3183757-B1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM CLAP CO LTD (KR) 2022-05-04 EP disclosed
CN-107004768-B Organic semiconductor composition containing a liquid medium 巴斯夫欧洲公司 2020-08-21 CN disclosed
CN-111060620-A Method for analyzing and detecting effective components in spices 上海微谱化工技术服务有限公司 2020-04-24 CN disclosed
US-10454037-B2 Organic semiconductor composition comprising a liquid medium BASF SE (DE) 2019-10-22 US disclosed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US disclosed
US-5008442-A Surface-active compounds on the basis of arylated fatty substances and their use HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-16 US disclosed
US-4597906-A Surface-active compounds on the basis of arylated fatty substances and their use HOECHST AKTIENGESELLSCHAFT (DE) 1986-07-01 US disclosed
US-4446039-A Organic compositions containing hydroxy-aromatic compounds useful as additives for fuels and lubricants THE LUBRIZOL CORPORATION (US) 1984-05-01 US disclosed
EP-0031253-B1 PROCESS FOR PREPARING 3,4-SUBSTITUTED BENZALDEHYDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-10-05 EP disclosed
US-4335263-A MANY STEPS, STARTING WITH ACETYLATION OF M-CRESOL OR P-CRESOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-06-15 US disclosed
US-4333732-A Dyestuff preparations containing oxalkylates of modified natural rosin acids HOECHST AKTIENGESELLSCHAFT (DE) 1982-06-08 US disclosed
US-4312631-A DISPERSANTS, EMULSIFIERS, WETTING AGENTS, ANIONIC SURFACTANTS HOECHST AKTIENGESELLSCHAFT (DE) 1982-01-26 US disclosed
US-4297270-A ETH- OR PROPOXYLATED ESTER DERIVATIVES; DISPERSANTS; EMULSIFIERS; WETTING AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1981-10-27 US disclosed
EP-0031253-A1 Process for preparing 3,4-substituted benzaldehydes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-07-01 EP disclosed
US-4230624-A CYCLIZATION, BASIC CATALYSTS AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (FR) 1980-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10454037-B2 Organic semiconductor composition comprising a liquid medium CRY1, NEFM, OR10J3 ESR1 2229/4885ESR2 3650/4885TRPA1 14/4885
US-10224485-B2 Process for preparing a crystalline organic semiconductor material STOM, SPOP, TTR ESR1 3620/4885ESR2 4641/4885TRPA1 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.